BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30509108)

  • 1. Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway.
    Wang ST; Liu LB; Li XM; Wang YF; Xie PJ; Li Q; Wang R; Wei Q; Kang YH; Meng R; Feng XH
    Neoplasma; 2019 Mar; 66(2):232-239. PubMed ID: 30509108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.
    Yang C; Yuan W; Yang X; Li P; Wang J; Han J; Tao J; Li P; Yang H; Lv Q; Zhang W
    Mol Cancer; 2018 Jan; 17(1):19. PubMed ID: 29386015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0008784 activates Wnt/β-catenin pathway to affect the proliferation and apoptosis of triple-negative breast cancer cells.
    Zhao Z; Han X; Nie C; Lin S; Wang J; Fang H
    Pathol Res Pract; 2023 Jan; 241():154185. PubMed ID: 36436315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
    Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H
    J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.
    Wang Q; Li Z; Hu Y; Zheng W; Tang W; Zhai C; Gu Z; Tao J; Wang H
    J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):323-331. PubMed ID: 31776835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway.
    Wang S; Li Q; Wang Y; Li X; Wang R; Kang Y; Xue X; Meng R; Wei Q; Feng X
    Biochem Biophys Res Commun; 2018 Nov; 505(4):996-1002. PubMed ID: 30314706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinnamaldehyde induces cell apoptosis mediated by a novel circular RNA hsa_circ_0043256 in non-small cell lung cancer.
    Tian F; Yu CT; Ye WD; Wang Q
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1260-1266. PubMed ID: 28958934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CircRNA-ITCH on proliferation and apoptosis of hepatocellular carcinoma cells through inhibiting Wnt/β-catenin signaling pathway.
    Yang B; Zhao J; Huo T; Zhang M; Wu X
    J BUON; 2020; 25(3):1368-1374. PubMed ID: 32862578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-10b promoted melanoma progression through Wnt/β-catenin pathway by repressing ITCH expression.
    Wang S; Wu Y; Xu Y; Tang X
    Gene; 2019 Aug; 710():39-47. PubMed ID: 31129246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
    Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
    BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.
    Zou Y; Zheng S; Xiao W; Xie X; Yang A; Gao G; Xiong Z; Xue Z; Tang H; Xie X
    Carcinogenesis; 2019 Dec; 40(12):1469-1479. PubMed ID: 31001629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway.
    Li Y; Wang Z; Su P; Liang Y; Li Z; Zhang H; Song X; Han D; Wang X; Liu Y; Yang J; Chen B; Wang L; Zhao W; Yang Q
    Mol Ther; 2022 Jan; 30(1):415-430. PubMed ID: 34450253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
    Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
    Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathway.
    Yao Y; Hua Q; Zhou Y; Shen H
    Biomed Pharmacother; 2019 Mar; 111():1367-1375. PubMed ID: 30841451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
    Luo L; Gao Y; Sun X
    Cancer Biomark; 2018; 23(4):505-513. PubMed ID: 30347599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.